Skip to main content
Top
Published in: Head and Neck Pathology 4/2019

01-12-2019 | Sine qua non Radiology-Pathology

Null Cell Adenoma of the Pituitary: Pseudo-rosettes Say It Best When Immunohistochemistry Says Nothing At All!

Authors: Vikram Singh, Kirti Gupta, Pravin Salunke, Sivashanmugam S. Dhandapani

Published in: Head and Neck Pathology | Issue 4/2019

Login to get access

Abstract

Null cell adenoma is composed of adenohypophyseal cells that show no evidence of any specific cell type differentiation by immunohistochemistry or transcription factors like pituitary-specific positive transcription factor 1 and steroidogenic factor 1. Though rare, pituitary ependymoma and germinoma are also known to occur at sellar region and in such instances, it is challenging to differentiate them from a pituitary null cell adenoma featuring papillary architecture and perivascular pseudo-rosettes. We describe a case of an elderly diabetic lady presenting with headache and blurring of vision for past 3 months due to a sellar tumour. The histology was diagnostically challenging with notable presence of numerous perivascular pseudo-rosettes and negative immunoreactivity for all pituitary hormones. The differential diagnosis and importance of ancillary techniques is discussed.
Literature
1.
go back to reference Lloyd RV, Osamura RY, Klöppel G, Rosai J, editors. WHO classification of tumours of endocrine organs. 4th ed. IARC: Lyon, 2017. pp. 34–38. Lloyd RV, Osamura RY, Klöppel G, Rosai J, editors. WHO classification of tumours of endocrine organs. 4th ed. IARC: Lyon, 2017. pp. 34–38.
2.
go back to reference Nishioka H, Inoshita N, Mete O, Asa SL, Hayashi K, Takeshita A, Fukuhara N, Yamaguchi-Okada M, Takeuchi Y, Yamada S. The complementary role of transcription factors in the accurate diagnosis of clinically nonfunctioning pituitary adenomas. Endocr Pathol. 2015;26:349–55.CrossRef Nishioka H, Inoshita N, Mete O, Asa SL, Hayashi K, Takeshita A, Fukuhara N, Yamaguchi-Okada M, Takeuchi Y, Yamada S. The complementary role of transcription factors in the accurate diagnosis of clinically nonfunctioning pituitary adenomas. Endocr Pathol. 2015;26:349–55.CrossRef
3.
go back to reference Nishioka H, Inoshita N. New WHO classification of pituitary adenomas (4th edition): assessment of pituitary transcription factors and the prognostic histological factors. Brain Tumor Pathol. 2018;35:57–61.CrossRef Nishioka H, Inoshita N. New WHO classification of pituitary adenomas (4th edition): assessment of pituitary transcription factors and the prognostic histological factors. Brain Tumor Pathol. 2018;35:57–61.CrossRef
4.
go back to reference Ramesh VG, Karthikeyan KV, Rajaraman S, Rao R. Pituitary ependymoma: report of a rare case with an insight into the histogenesis. Neurol India. 2013;61:545–6.CrossRef Ramesh VG, Karthikeyan KV, Rajaraman S, Rao R. Pituitary ependymoma: report of a rare case with an insight into the histogenesis. Neurol India. 2013;61:545–6.CrossRef
5.
go back to reference Kontogeorgos G, Thodou E. The gonadotroph origin of null cell adenomas. Hormones (Athens) 2016;15:243–7.CrossRef Kontogeorgos G, Thodou E. The gonadotroph origin of null cell adenomas. Hormones (Athens) 2016;15:243–7.CrossRef
6.
go back to reference Kontogeorgos G, Kovacs K, Horvath E, Scheithauer BW. Null cell adenomas, oncocytomas, and gonadotroph adenomas of the human pituitary: an immunocytochemical and ultrastructural analysis of 300 cases. Endocr Pathol. 1993;4:20.CrossRef Kontogeorgos G, Kovacs K, Horvath E, Scheithauer BW. Null cell adenomas, oncocytomas, and gonadotroph adenomas of the human pituitary: an immunocytochemical and ultrastructural analysis of 300 cases. Endocr Pathol. 1993;4:20.CrossRef
Metadata
Title
Null Cell Adenoma of the Pituitary: Pseudo-rosettes Say It Best When Immunohistochemistry Says Nothing At All!
Authors
Vikram Singh
Kirti Gupta
Pravin Salunke
Sivashanmugam S. Dhandapani
Publication date
01-12-2019
Publisher
Springer US
Published in
Head and Neck Pathology / Issue 4/2019
Electronic ISSN: 1936-0568
DOI
https://doi.org/10.1007/s12105-018-0972-9

Other articles of this Issue 4/2019

Head and Neck Pathology 4/2019 Go to the issue